Natco Pharma increases its stake in Adcock Ingram to 49% through a ₹1,060 crore acquisition, enhancing its market presence.

Natco Pharma increases its stake in Adcock Ingram to 49% through a ₹1,060 crore acquisition, enhancing its market presence.

Generic drugmaker Natco Pharma has completed the acquisition of an additional 13.25% stake in South African pharmaceutical and healthcare company Adcock Ingram Holdings…